Trials / Conditions / Activated PI3K-delta Syndrome
Activated PI3K-delta Syndrome
3 registered clinical trials studyying Activated PI3K-delta Syndrome — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome NCT06694363 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome NCT03383380 | Children's Hospital of Fudan University | Phase 1 / Phase 2 |
| Completed | Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients NCT02593539 | GlaxoSmithKline | Phase 2 |